Community-acquired pneumonia: Influence of management practices on length of hospital stay

Internal Medicine Journal

Volumn 34, Issue 3, 2004, Pages 91-97

  Laing, R ^a,e   Coles, C ^d   Chambers, S ^b   Frampton, C ^a   Jennings, L ^c   Karalus, N ^d   Mills, G ^d   Town, G I ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

^d WAIKATO HOSPITAL   (New Zealand)

^e Canterbury Resp Research Group   (New Zealand)

Author keywords

Adult community acquired pneumonia; Duration of i.v. Antibiotics; Length of hospital stay

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW ZEALAND; PHYSICIAN'S PRACTICE PATTERNS; PNEUMONIA;

EID: 1942505388     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2004.00544.x     Document Type: Article

References (24)

1. Cazzola M, Blasi F, Allegra L. Critical evaluation of guidelines for the treatment of lower respiratory tract bacterial infections. Resp Med 2001; 95: 95-108.
2. Fine MJ, Singer DE, Phelps AL, Hanusa BH, Kapoor WN. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care 1993; 31: 371-80.
3. Rosenthal GE, Harper DL, Shah A, Covinsky KE. A regional evaluation of variation in low-severity hospital admissions. J Gen Int Med 1997; 12: 416-22.
4. Schaberg T, Gialdroni-Grassi G, Huchon G, Leophonte P, Manresa F, Woodhead M. An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. Thorax 1996; 51: 1017-22.
5. Gilbert K, Gleason PP, Singer DE, Marrie TJ, Coley CM, Obrosky DS et al. Variations in antimicrobial use and cost in more than 2 000 patients with community-acquired pneumonia. Am J Med 1998; 104: 17-27.
6. Whittle J, Lin CJ, Lave JR, Fine MJ, Delaney KM, Joyce DZ et al. Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia. Med Care 1998; 36: 977-87.
7. Feagan BG, Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. Can Med Ass J 2000; 162: 1415-20.
8. Burns LR, Wholey DR. The effects of patient, hospital, and physician characteristics on length of stay and mortality. Med Care 1991; 29: 251-71.
9. Fine MJ, Medsger AR, Stone RA, Marrie TJ, Coley CM. Singer DE et al. The hospital discharge decision for patients with community-acquired pneumonia. Arch Intern Med 1997; 157: 47-56.
10. Laing R, Slater W, Coles C, Chambers S, Frampton C, Jackson R et al. Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology. N Z Med J 2001; 114: 488-92.
11. Statistics New Zealand, Te Tari Tautau. [Internet] Wellington: New Zealand Government; [cited 19 March 2003]. Available from: http://www.stats. govt.nz/census.htm.
12. Neill AM, Martin IR, Weir R, Anderson R, Chereshsky A, Epton MJ et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010-16.
13. Karalus NC, Cursons RT, Leng RA, Mahood CB, Rothwell RP, Hancock B et al. Community acquired pneumonia: aetiology and prognostic index evaluation. Thorax 1991; 46: 413-18.
14. Research Committee of the British Thoracic Society and the Public Health Laboratory Service. Community acquired pneumonia in adults in British hospitals in 1982-83: a survey in aetiology, mortality, prognostic factors and outcomes. Q J Med 1982; 62: 195-220.
15. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-50.
16. Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 1999; 159: 970-80.
17. Siegel RA. Strategies for early discharge of the hospitalized patient with community-acquired pneumonia. Clin Chest Med 1999; 20: 599-605.
18. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001; 163: 1730-54.
19. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000; 31: 347-82.
20. Ramirez JA, Vargas S, Ritter GW, Brier ME, Wright A, Smith S et al. A. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch Intern Med 1999; 159: 2449-54.
21. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-acquired pneumonia intervention trial assessing levofloxacin. JAMA 2000; 283: 749-55.
22. Shillington AC, Dempsey CL, Goliak MK, Jewell MA, Farley PA. Timing of intravenous to oral switch therapy for hospitalized pneumonia: an outcome evaluation in 41 U.S. hospitals. 5th International Conference on Macrolides, Streptogramins, Ketolides and Oxazolidinones; 2000 January; Seville, Spain. Atlanta, USA: ICMAS Secretariat; 4: A30.
23. Omidvari K, de Boisblanc BP, Karam G, Nelson S, Haponik E, Summer W. Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis. Resp Med 1998; 92: 1032-9.
24. Siegel RE, Alicea M, Lee A, Blaiklock R, Schilero GJ. Inpatient treatment of community-acquired pneumonia with one dose of IV therapy prior to switch to oral therapy. Am J Resp Crit Care Med 1999; 159: A845.